Market Place
Sourcing Support
FDA approves InteRNA Technologies’ Phase I solid tumour treatment study
03 Dec 2021 //
CLINICALTRIALSARENA
FDA Clears InteRNA`s IND for Phase I Trial of INT-1B3 in Advanced Solid Tumors
02 Dec 2021 //
BUSINESSWIRE
InteRNA Technologies Establishes Clinical Advisory Board, Appoints New Members
19 Oct 2021 //
BUSINESSWIRE
InteRNA Appoints Andrea van Elsas to its Supervisory Board
12 Oct 2021 //
BUSINESSWIRE
InteRNA Publishes Preclinical Data from Investigational microRNA INT-1B3
24 Mar 2021 //
BUSINESSWIRE
InteRNA Publishes Preclinical Data from Investigational microRNA INT-1B3
23 Mar 2021 //
BUSINESSWIRE
InteRNA Technologies Awarded € 2.7M Clinical Innovation Credit from Dutch GovT
11 Mar 2021 //
BUSINESSWIRE
InteRNA Awarded € 2.7M Clinical Innovation Credit from Dutch Government
10 Mar 2021 //
BUSINESSWIRE
InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial
16 Feb 2021 //
BUSINESSWIRE
InteRNA Technologies begins dosing in solid tumour drug trial
16 Feb 2021 //
CLINICALTRIALSARENA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.